Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CELL-VAD Pilot
NCT06154044Phase 2Recruiting
- Sponsor
- University Medical Centre Ljubljana
- Start
- May 2022
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in heart failure (HF) and dilated cardiomyopathy (DCM), sponsored by University Medical Centre Ljubljana. Primary endpoints: Left Ventricular Ejection Fraction at 6 months, Left Ventricular End-Systolic and End-Diastolic Dimensions at 6 months and 7 more. Started May 2022; status: recruiting.
02
Conditions
heart failure (HF)dilated cardiomyopathy (DCM)
Beyond the preview
Go deeper on NCT06154044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06154044.